Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:TEM 8 October 2025 - 25 February 2026

Tempus AI (TEM) stock drops 4% in premarket as 2026 outlook lands after Q4 results

Tempus AI (TEM) stock drops 4% in premarket as 2026 outlook lands after Q4 results

Tempus AI shares fell 4.1% to $55.59 in premarket trading after the company set 2026 revenue guidance at $1.59 billion and projected adjusted EBITDA of $65 million. Fourth-quarter revenue jumped 83% to $367.2 million, with MRD test volume up 56% to about 4,700. The company still posted a net loss and relied on stock-based compensation. The stock closed Tuesday at $57.95.
25 February 2026
··
Tempus AI (TEM) Stock: FDA Wins, Q3 Earnings, and Analyst Forecasts – December 6, 2025

Tempus AI (TEM) Stock: FDA Wins, Q3 Earnings, and Analyst Forecasts – December 6, 2025

Tempus AI shares closed near $76.70 on December 5, 2025, up 52% from a year earlier, with a market cap around $13.6 billion. The stock trades at a forward price-to-sales ratio of 8–10x and a negative P/E near –65. Recent analyst notes and institutional buying have fueled debate over valuation as volatility remains high. Tempus went public in June 2024 and focuses on AI-driven precision medicine.
6 December 2025
··
Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI shares closed at a record $102.31 on October 8, 2025, nearly tripling year-to-date after FDA clearance for new AI diagnostics and the $81.3 million acquisition of Paige. Q2 revenue surged 89.6% to $314.6 million, with net losses narrowing and positive adjusted EBITDA forecast for 2025. Market cap stands near $17 billion.
8 October 2025
···

Stock Market Today

  • 3 Worst-Performing Singapore Blue Chips in 2026: Genting Singapore Leads Decline
    March 20, 2026, 8:29 AM EDT. Singapore's stock market faced headwinds in early 2026. Genting Singapore Limited (SGX: G13) emerged as the worst YTD performer among blue chips, with its share price down 8.3% by mid-March. The integrated resort operator's FY2025 net profit plunged 33% year-on-year to S$390.3 million amid a softer gaming recovery and ongoing renovations at Resorts World Sentosa. Gaming segment weakness, intensified competition from Marina Bay Sands, and hotel occupancy challenges weighed on results. Despite a recovering broader gaming market, Genting Singapore's transformation phase and operational disruptions have depressed earnings. The outlook hinges on completion of renovations and stabilizing non-gaming segments. Investors watch for potential turnaround triggers amid income opportunities re-emerging across the Singapore market.
Go toTop